Search the Newsreel

H.C. Wainwright Maintains Cybin(HELP.US) With Buy Rating, Raises Target Price to $70

H.C. Wainwright has reiterated its Buy rating on Cybin (HELP.US) and increased its price target to $70. This updated guidance reflects a positive outlook from the analyst firm regarding Cybin's future performance.

Chief Financial Officer Greg Cavers Sold A Bunch Of Shares In Cybin

Cybin's Chief Financial Officer, Greg Cavers, recently sold US$431k worth of stock at US$6.10 per share, representing 45% of his holding. This insider sale, occurring below the current market price of US$7.25, raises concerns, although the company's insider ownership at 12% is considered sufficient …

Cybin (NEOE:HELP) Stock Forecast & Analyst Predictions

Cybin (NEOE:HELP) is forecast to grow earnings by 52.4% and revenue by 63.1% per annum, although analysts no longer expect the company to break even in the foreseeable future, projecting significant losses. Recent developments include the completion of enrollment for a Phase 3 study …

Helport AI Guided 1,045 Users to Submit Loan Materials in Mexico

Helport AI (NASDAQ: HPAI) announced the commercial validation of its AI Labor customer acquisition workflow in Mexico, successfully guiding 1,045 users to complete loan applications. This builds on their existing collections deployments, with the platform completing 744,249 outbound customer connections and converting 2,093 users …

Helport AI validates customer acquisition platform in Mexico

Helport AI Limited has successfully validated its AI-powered customer acquisition platform in Mexico for consumer lending, processing over 744,000 outbound connections and converting a significant number of users into registered and loan-applying customers. Despite this operational success, the company faces financial challenges, including an …

Helport AI Limited Receives Standard Nasdaq Notification Regarding Minimum Bid Price Requirement

Helport AI Limited (NASDAQ: HPAI) announced it received a standard notification from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's shares traded below $1.00 for 30 consecutive business days, from June 1, 2026, to July 14, 2026. Helport AI has 180 …

Helport AI Limited Receives Nasdaq Notice for Minimum Bid Price Non-Compliance

Helport AI Limited received a deficiency letter from Nasdaq for not meeting the minimum bid price requirement. The company has 180 calendar days to regain compliance, during which its ordinary shares will continue to trade on the Nasdaq Capital Market. To remedy the deficiency, …

Helport AI receives Nasdaq notice on minimum bid price rule By Investing.com

Helport AI Limited has received a notice from Nasdaq regarding its failure to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until January 11, 2027, to regain compliance by maintaining a …

Helport AI Has 180 Calendar Days to Reach Nasdaq's $1 Bid Minimum

Helport AI (NASDAQ: HPAI) received a standard notification from Nasdaq on July 15, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company has 180 calendar days, until January 11, 2027, to regain compliance by achieving a closing bid …

Cybin (HELP) Advances Psychedelic Depression Drug to Phase 3 Amid Fresh Funding – What Really Matters?

Cybin, operating as Helus Pharma, has advanced its lead psychedelic drug candidate HLP003 into a Phase 3 trial for major depressive disorder and recently secured US$50 million in funding. This development is crucial for Cybin's investment narrative, as success in Phase 3 could lead …

Cybin (HELP) Is Up 6.2% After Advancing HLP003 To Phase 3 And Raising US$50 Million

Cybin, operating as Helus Pharma, has advanced its lead psychedelic candidate HLP003 into a Phase 3 trial for major depressive disorder. The company also recently completed an underwritten public offering, raising US$50 million to fund development. This progress positions HLP003 as a potential clinic-based …

Cybin Inc. Common Stock (HELP) Stock Forecast & Price Prediction 2026–2030